Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy

BACKGROUND: The efficacy, safety, and ease of use of rivaroxaban may reduce anticoagulation‐treatment burden and improve nonvalvular atrial fibrillation (NVAF) patient satisfaction compared with vitamin K antagonists (VKAs). HYPOTHESIS: Transitioning from a VKA to rivaroxaban improves treatment sati...

Full description

Saved in:
Bibliographic Details
Published in:Clin Cardiol
Main Authors: Coleman, Craig I., Haas, Sylvia, Turpie, Alexander G.G., Kuhls, Silvia, Hess, Susanne, Evers, Thomas, Amarenco, Pierre, Kirchhof, Paulus, Camm, A. John
Format: Artigo
Language:Inglês
Published: Wiley Periodicals, Inc. 2016
Subjects:
Clinical Investigations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490868/
https://ncbi.nlm.nih.gov/pubmed/27362695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22565
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items